Literature DB >> 11574081

Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?

P Bachellier1, H Nakano, P D Oussoultzoglou, J C Weber, K Boudjema, P D Wolf, D Jaeck.   

Abstract

BACKGROUND: Whether or not superior mesentericoportal venous resection (SM-PVR) associated with pancreaticoduodenectomy (PD) is safe and worthwhile has not been fully confirmed. The aim of the present study was to investigate results of this surgical procedure performed for pancreatic head and periampullary neoplasms.
METHODS: As a first analysis, postoperative morbidity and mortality after PD with (n = 31) or without SM-PVR (n = 119) were investigated in 150 patients with pancreatic head and periampullary neoplasms. As a second analysis, rates of margin-negative resection and survival after SM-PVR (n = 21) and without SM-PVR (n = 66) were compared in 87 patients with pancreatic ductal adenocarcinoma of the pancreatic head. In these patients undergoing SM-PVR (n = 21), survival rate was investigated in patients who did (n = 13) and did not (n = 8) undergo a margin-negative resection.
RESULTS: In the first analysis, duration of surgery and volume of blood transfused perioperatively were higher in patients undergoing SM-PVR. However, mortality, morbidity rates, and mean hospital stay did not differ between patients who did undergo SM-PVR (31 patients, 3.2%, 48.4%, and 22.2 days, respectively) and who did not (119 patients, 2.5%, 47.1%, 25.9 days, respectively). No postoperative death occurred in the recent part of the present study, since 1994, in patients undergoing SM-PVR. In the second analysis of pancreatic ductal adenocarcinoma, rates of margin-negative resection and 2-year survival did not significantly differ between patients who did and did not undergo SM-PVR (62% and 22%, respectively, versus 73% and 24%). In patients undergoing SM-PVR, survival rate was significantly higher for patients undergoing a margin-negative resection (n = 13) than for patients undergoing a macroscopic or microscopic margin-positive resection (n = 8, 2-year survival = 57.1% versus 0%, P <0.05).
CONCLUSION: PD combined with SM-PVR can be performed safely. This surgical procedure is followed by a promising survival rate and can be recommended in order to obtain a margin-negative resection; however, candidates for SM-PVR should be carefully selected.

Entities:  

Mesh:

Year:  2001        PMID: 11574081     DOI: 10.1016/s0002-9610(01)00686-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  52 in total

1.  [Surgical interdisciplinarity-abdomen excluding the pelvis].

Authors:  T Junginger
Journal:  Chirurg       Date:  2004-04       Impact factor: 0.955

2.  Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis.

Authors:  Yanming Zhou; Zhiming Zhang; Yujian Liu; Bin Li; Donghui Xu
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

Review 3.  Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review.

Authors:  Terence C Chua; Akshat Saxena
Journal:  J Gastrointest Surg       Date:  2010-04-09       Impact factor: 3.452

Review 4.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

6.  Long mesentericoportal vein resection and end-to-end anastomosis without graft in pancreaticoduodenectomy.

Authors:  Ji Zhang; Hong-Gang Qian; Jia-Hua Leng; Ming Cui; Hui Qiu; Guo-Quan Zhou; Jian-Hui Wu; Yong Yang; Chun-Yi Hao
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

7.  Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study.

Authors:  Chunyou Wang; Heshui Wu; Jiongxin Xiong; Feng Zhou; Jing Tao; Tao Liu; Gang Zhao; Shanmiao Gou
Journal:  J Gastrointest Surg       Date:  2008-08-06       Impact factor: 3.452

8.  Durability of portal venous reconstruction following resection during pancreaticoduodenectomy.

Authors:  Rory L Smoot; John D Christein; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

Review 9.  Ductal pancreatic adenocarcinoma.

Authors:  Thomas Seufferlein; Marc Porzner; Volker Heinemann; Andrea Tannapfel; Martin Stuschke; Waldemar Uhl
Journal:  Dtsch Arztebl Int       Date:  2014-05-30       Impact factor: 5.594

Review 10.  Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Authors:  Markus Schäfer; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.